A detailed history of Moody National Bank Trust Division transactions in Repligen Corp stock. As of the latest transaction made, Moody National Bank Trust Division holds 1,444 shares of RGEN stock, worth $212,195. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,444
Holding current value
$212,195
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$119.79 - $167.35 $172,976 - $241,653
1,444 New
1,444 $214,000
Q4 2021

Jan 13, 2022

SELL
$247.59 - $304.47 $173,065 - $212,824
-699 Closed
0 $0
Q3 2021

Oct 07, 2021

BUY
$194.77 - $324.21 $136,144 - $226,622
699 New
699 $202,000
Q1 2019

Apr 11, 2019

SELL
$49.45 - $62.8 $4,450 - $5,652
-90 Closed
0 $0
Q4 2018

Jan 07, 2019

BUY
$48.26 - $68.88 $4,343 - $6,199
90 New
90 $5,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.